| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |